IN8BIO INC
INAB · NASDAQ
Updated at 2026-10-14 09:31:18
- Today's High
- $1.26
- Today’s Low
- $1.18
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.35
- Previous Close
- $1.23
- Volume
- 39.32K
- Market Cap
- $12.12M
- P/E Ratio
- --
- EPS
- $-2.05
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 350 5TH AVENUE, NEW YORK, NY, UNITED STATES, 10118
- Country
- US
- Listing Date
- 2020-11-12
- Fiscal Year End
- December
- Shares Outstanding
- 9.85M
- CIK
- 0001740279
- Website
- www.in8bio.com
IN8bio, Inc., a clinical-stage biotechnology company, is focused on developing new therapies for the treatment of cancers, including solid tumors using genetically modified, autologous, allogeneic gamma-delta T cells. The company is headquartered in New York, New York.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$4.78M
2026-03-31
$4.76M
2025-12-31
$4.94M
2025-09-30
$3.85M
Net Income
2026-06-30
-$4.78M
2026-03-31
-$5.09M
2025-12-31
-$4.94M
2025-09-30
-$3.85M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.25
2026-03-31
$-0.26
2025-12-31
$-0.45
2025-09-30
$-0.85
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$4.27M
2026-03-31
-$4.59M
2025-12-31
-$4.51M
2025-09-30
-$3.32M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $4.78M | $4.76M | $4.94M | $3.85M |
| Net Income | -$4.78M | -$5.09M | -$4.94M | -$3.85M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.25 | $-0.26 | $-0.45 | $-0.85 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$4.27M | -$4.59M | -$4.51M | -$3.32M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.